LETARA is used for the treatment of breast cancer in post-menopausal women i.e. women who no longer have periods, either because of their natural age or following surgery or chemotherapy. LETARA contains the active ingredient, 2.5 mg of letrozole and is presented in tablets.

LETARA (Letrozole) is indicated for first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown, locally advanced or metastatic breast cancer.

Super Health intends to make sure that its consumers get accurate information, are reviewed by an expert and are error-free. However, the information mentioned here should not be used as a replacement for the advice of a qualified physician. The information given here is for informational purposes only, which may not cover all possible precautions, side effects, contraindications, or drug interactions. Consult your doctor and discuss your queries related to any medicine or disease.